Gabriel Cavazos

Gabriel Cavazos has a diverse work experience in the finance and pharmaceutical industries. Gabriel began their career at Pfizer in 1999, focusing on molecular biology research. Gabriel then joined Merck in 2000, where they primarily worked on cardiovascular disease. In 2007, Gabriel transitioned to JPMorgan as an associate in mergers and acquisitions. In 2008, they moved to Leerink Partners and assumed the role of Senior Managing Director.

Gabriel Cavazos holds an MBA degree in Finance and Accounting from Northwestern University - Kellogg School of Management. Prior to that, they completed their undergraduate studies at the University of Michigan, where they obtained a Bachelor of Science degree in Cellular & Molecular Biology. In addition to their academic qualifications, Gabriel has also earned several certifications from FINRA, including the FINRA Series 24 in 2018, the FINRA Series 63 in 2007, and the FINRA Series 7 in 2007.